ML
GILD icon

McAdam LLC’s Gilead Sciences GILD Stock Holding History

McAdam LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Sell
25,513
-35
-0.1% -$4.61K 0.12% 83
2026
Q1 		$3.56M Buy
25,548
+177
+0.7% +$24.8K 0.16% 80
2025
Q4 		$3.11M Sell
25,371
-44
-0.2% -$5.35K 0.14% 85
2025
Q3 		$2.82M Buy
25,415
+1,787
+8% +$203K 0.14% 82
2025
Q2 		$2.62M Sell
23,628
-2,725
-10% -$290K 0.14% 78
2025
Q1 		$2.95M Buy
26,353
+981
+4% +$101K 0.18% 71
2024
Q4 		$2.34M Buy
25,372
+3,627
+17% +$327K 0.13% 88
2024
Q3 		$1.82M Sell
21,745
-77
-0.4% -$5.88K 0.1% 96
2024
Q2 		$1.5M Sell
21,822
-436
-2% -$29.1K 0.09% 98
2024
Q1 		$1.63M Buy
22,258
+12,690
+133% +$976K 0.1% 91
2023
Q4 		$775K Sell
9,568
-1,224
-11% -$95.2K 0.06% 125
2023
Q3 		$809K Buy
10,792
+1,471
+16% +$113K 0.07% 125
2023
Q2 		$718K Buy
9,321
+65
+0.7% +$5.18K 0.06% 129
2023
Q1 		$768K Buy
9,256
+8
+0.1% +$663 0.07% 124
2022
Q4 		$671K Sell
9,248
-1,107
-11% -$87.7K 0.07% 91
2022
Q3 		$639K Buy
10,355
+678
+7% +$42.8K 0.07% 117
2022
Q2 		$598K Buy
9,677
+577
+6% +$35.7K 0.06% 124
2022
Q1 		$541K Sell
9,100
-148
-2% -$9.46K 0.05% 106
2021
Q4 		$671K Buy
+9,248
New +$637K 0.07% 91
2018
Q4 		– Sell
-435
Closed -$34K – 252
2018
Q3 		$34K Sell
435
-195
-31% -$14.7K 0.01% 197
2018
Q2 		$45K Hold
630
– – 0.02% 160
2018
Q1 		$48K Buy
+630
New +$50.1K 0.02% 160

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

McAdam LLC's GILD Position: Q2 2026 in Review

McAdam LLC reduced its Gilead Sciences (GILD) stake by 0.14% in Q2 2026, selling an estimated $4.61K and leaving 25,513 shares worth $3.22M. The position accounts for 0.12% of the portfolio, ranked #83.

McAdam LLC first reported a position in GILD in Q1 2018 and has held it in 22 quarters since. The position peaked at $3.56M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • McAdam LLC held 25,513 shares of Gilead Sciences worth $3.22M as of Q2 2026.
  • McAdam LLC sold 35 Gilead Sciences shares in Q2 2026, an estimated $4.61K.
  • Gilead Sciences made up 0.12% of McAdam LLC's portfolio in Q2 2026, its #83 holding.
  • McAdam LLC first reported a position in Gilead Sciences in Q1 2018 and has held it in 22 quarters since.
  • McAdam LLC's Gilead Sciences position peaked at $3.56M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.